For instance, low-grade gliomas have been classified according to the 1p and 19q loci co-deletion as well as the mutations in the IDH1 and IDH2 genes; tumors without these alterations have been shown to be clinically and molecularly similar to high-grade tumors (Claus et al., 2015). This evidence concerns the gene IDH2 and central nervous system cancer.